Development and validation of a sensitive analytical method for the simultaneous determination of buprenorphine and norbuprenorphine in human plasma
- 20 February 2001
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 51 (2) , 147-151
- https://doi.org/10.1016/s0939-6411(00)00135-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Determination of Buprenorphine in Human Plasma by Gas Chromatography-Positive Ion Chemical Ionization Mass Spectrometry and Liquid Chromatography-Tandem Mass SpectrometryJournal of Analytical Toxicology, 1997
- Bioavailability of Sublingual BuprenorphineThe Journal of Clinical Pharmacology, 1997
- Simultaneous Assay of Buprenorphine and Norbuprenorphine by Negative Chemical Ionization Tandem Mass Spectrometry*Journal of Analytical Toxicology, 1996
- Quantitative determination of buprenorphine and its active metabolite, norbuprenorphine, in human plasma by gas chromatography—chemical ionization mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Analysis of buprenorphine and its n-dealkylated metabolite in plasma and urine by selected-ion monitoringJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- 63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and fecesJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Biliary excretion, metabolism and enterohepatic circulation of buprenorphineXenobiotica, 1981
- Buprenorphine Suppresses Heroin Use by Heroin AddictsScience, 1980
- Human Pharmacology and Abuse Potential of the Analgesic BuprenorphineArchives of General Psychiatry, 1978
- AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENTBritish Journal of Pharmacology, 1977